NCT03317418

Brief Summary

The aim of this study is to examine the variability of culture media composition based on the ATR-FTIR (Attenuated Total Reflectance-Fourier Transform Infrared Spectroscopy) technique on the day of embryo transfer/vitrification. In addition, the study will explore whether variations detected in the culture medium can be linked to embryo quality and the chances of achieving pregnancy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 23, 2017

Completed
9 days until next milestone

Study Start

First participant enrolled

November 1, 2017

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

June 23, 2022

Status Verified

June 1, 2022

Enrollment Period

6 years

First QC Date

October 18, 2017

Last Update Submit

June 22, 2022

Conditions

Infertility

Outcome Measures

Primary Outcomes (2)

  • Spectrometry in embryo culture media

    Definition of spectrometry in embryo culture media

    One year

  • Embryo quality

    The spectrometry results will be linked to embryo quality through the linkage between spectrometry results as indicated on Absorbance Graph and embryo quality judged by accepted criteria

    One year

Secondary Outcomes (1)

  • Cycle outcomes

    One year

Interventions

ATR-FTIR SpectrophotometryOTHER

Spectrometry imaging

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women attending the fertility clinic at Hillel Yaffe Medical Center

You may qualify if:

  • Women undergoing IVF treatments with at least 4 embryos

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hillel Yaffe Medical Center

Hadera, 38100, Israel

RECRUITING

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Einat Shalom Paz, MD

    Hillel Yaffe Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nardin Aslih, MD

CONTACT

972-54-4843909nardin_aslih@yahoo.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 18, 2017

First Posted

October 23, 2017

Study Start

November 1, 2017

Primary Completion

November 1, 2023

Study Completion

November 1, 2023

Last Updated

June 23, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations

IL(1)